l General Information |
Product Name | Lansoprazole |
General description | Lansoprazole is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity. |
Synonym | 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole; Prevacid; Bamalite; Monolitum; Limpidex; |
Purity | ≥98%(HPLC) | CAS Number | 103577-45-3 |
Formula | C16H14F3N3O2S | Molecular Weight | 369.36 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or brownish solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | ≥10mg/mL |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Lansoprazole is an acid proton-pump inhibitor similar to omeprazole. Lansoprozole is active against Helicobacter pylori. The plasma elimination half-life of lansoprazole does not reflect its duration of suppression of gastric acid secretion. Thus, the plasma elimination half-life is less than two hours, while the acid inhibitory effect lasts more than 24 hours. |
Application | 1. Proton Pump Inhibitors Compounds that inhibit H(+)-K(+)-exchanging ATPase. They are used as anti-ulcer agents and sometimes in place of hisstamine H2 antagonists for gastroesophageal reflux. 2. Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. This has included antibiotics to treat helicobacter infections; Histamine H2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief. |
l Packaging & Storage |
Packaging | 250mg; 1g |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
